Clinical trial
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With…
NCT00304720 · Colorado Blood Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00304720 |
|---|---|
| Title | Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor |
| Official title | Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning With Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Family Donor Hematopoietic Cell Transplants |
| Lead sponsor | Colorado Blood Cancer Institute, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | Tacrolimus and MMF |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| First posted | Mar 20, 2006 |
| Last update posted | Feb 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: